论文部分内容阅读
大陆近几年在医保药品管理方面实施了改革,如放开药品的政府定价、药品实行零加成、药品招标采购实行“招采合一”“两票制”等。我国台湾地区的健康保险制度在国际上享有较高声誉,其中对于药品的管理也有一套成熟的规范体系。文章将海峡两岸在医保药品方面的管理制度进行了对比评析,汲取我国台湾地区药品制度中的先进之处,可以为大陆当前的药品管理改革提供借鉴。
In recent years, the mainland has implemented reforms in the administration of medical insurance and drug administration. For example, government pricing for drug liberalization, zero addition for medicines, and bidding and purchasing for medicine have been implemented. The health insurance system in Taiwan of our country enjoys a relatively high reputation in the world. Among them, there is also a mature regulatory system for the management of pharmaceutical products. The article makes a comparative assessment of the management system between the two sides of the Strait in respect of Medicare and insurance products and draws on the advanced aspects of the drug system in Taiwan of our country so as to provide reference for the current drug administration reform in the Mainland.